The pathophysiology of rhinitis. III. The control of IgG secretion
- PMID: 2480970
- DOI: 10.1016/0091-6749(89)90390-4
The pathophysiology of rhinitis. III. The control of IgG secretion
Abstract
To examine the sources of IgG in nasal secretions, nasal provocation tests with histamine (H) and methacholine (MC) were performed on 22 subjects. Nasal lavages were assayed for IgG, total protein, albumin (Alb), nonsecretory IgA (nonsIgA), and secretory IgA (sIgA). H stimulation dramatically increased the secretion of IgG, nonsIgA, and Alb and also increased the proportion of these proteins compared to total protein. H-induced protein secretion was significantly inhibited by nasal pretreatment with chlorpheniramine maleate but was unaffected by atropine sulfate. sIgA was also stimulated by H challenge, but unlike IgG and other vascular proteins, the proportion of sIgA to total protein (sIgA percent) decreased after H challenges. MC stimulation also increased secretion of IgG, Alb, nonsIgA, and sIgA but did not alter their proportions, compared to total protein. Topical atropine significantly inhibited secretion of all proteins, suggesting a mode of transportation mediated by glandular muscarinic receptor stimulation. Thus, MC can increase the amount of IgG secretion, whereas H increases both the amount and relative proportion of IgG in nasal secretions. These data suggest that pharmacologic stimulation of IgG into nasal secretions may be used as a total to modulate mucosal immunity.
Similar articles
-
Pathophysiology of rhinitis. 1. Assessment of the sources of protein in methacholine-induced nasal secretions.Am Rev Respir Dis. 1988 Aug;138(2):413-20. doi: 10.1164/ajrccm/138.2.413. Am Rev Respir Dis. 1988. PMID: 3057965
-
The pathophysiology of rhinitis. II. Assessment of the sources of protein in histamine-induced nasal secretions.Am Rev Respir Dis. 1989 Mar;139(3):791-800. doi: 10.1164/ajrccm/139.3.791. Am Rev Respir Dis. 1989. PMID: 2923378
-
Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions.J Clin Invest. 1989 Nov;84(5):1528-35. doi: 10.1172/JCI114329. J Clin Invest. 1989. PMID: 2681268 Free PMC article.
-
In vivo human models for the study of anticholinergic drugs.J Allergy Clin Immunol. 1995 May;95(5 Pt 2):1069-79. doi: 10.1016/s0091-6749(95)70210-5. J Allergy Clin Immunol. 1995. PMID: 7751524 Review.
-
Nasal pathophysiology.Respir Med. 1990 Nov;84 Suppl A:3-9; discussion 9-10. doi: 10.1016/s0954-6111(08)80001-7. Respir Med. 1990. PMID: 2287793 Review.
Cited by
-
Mechanism of interaction between ocular and nasal neurogenic inflammation in allergic rhinoconjunctivitis.Int Ophthalmol. 2019 Oct;39(10):2283-2294. doi: 10.1007/s10792-018-01066-5. Epub 2019 Jan 3. Int Ophthalmol. 2019. PMID: 30607863
-
Chemical Barrier Proteins in Human Body Fluids.Biomedicines. 2022 Jun 22;10(7):1472. doi: 10.3390/biomedicines10071472. Biomedicines. 2022. PMID: 35884778 Free PMC article. Review.
-
Innate antimicrobial activity of nasal secretions.Infect Immun. 1999 Jul;67(7):3267-75. doi: 10.1128/IAI.67.7.3267-3275.1999. Infect Immun. 1999. PMID: 10377100 Free PMC article.
-
Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples.Proteome Sci. 2009 Apr 17;7:17. doi: 10.1186/1477-5956-7-17. Proteome Sci. 2009. PMID: 19374746 Free PMC article.
-
[Role of nasal sinus infections in the pathogenesis of allergic and inflammatory diseases].Rev Fr Allergol Immunol Clin. 1998;38(4):258-263. doi: 10.1016/S0335-7457(98)80038-5. Epub 2005 May 16. Rev Fr Allergol Immunol Clin. 1998. PMID: 32287953 Free PMC article. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous